AnPac Bio-Medical Science Co., Ltd. Q2 2020 Results Conference Call September 10, 2020 8:00 AM ET Company Participants Phil Case - Marketing and Investor Relations Chris Yu - Chairman & CEO Edwards Tang - CFO Conference Call Participants Michael Irwin - Univest Securities Theodore O'Neill - Litchfield Hills Research John Vandermosten - Zacks Operator Good morning, everyone. Thank you for standing by. [Operator instructions]. The call is being recorded. At this time, I will turn the call over to Phil Case. ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR o SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIE ...